+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Biopharmaceuticals Market Research Reports

Regenerative Medicine Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Regenerative Medicine Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 139 Pages
  • Global
From
Hepatitis B Vaccine Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Hepatitis B Vaccine Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 146 Pages
  • Global
From
From
Monoclonal Antibodies Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Monoclonal Antibodies Market - Forecasts from 2022 to 2027

  • Report
  • December 2022
  • 142 Pages
  • Global
From
Influenza Vaccine Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Influenza Vaccine Market - Forecasts from 2022 to 2027

  • Report
  • March 2022
  • 124 Pages
  • Global
From
Biobetter Market - Forecasts from 2019 to 2024 - Product Thumbnail Image

Biobetter Market - Forecasts from 2019 to 2024

  • Report
  • December 2019
  • 120 Pages
  • Global
From
From
From
From
MEDI8897 Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

MEDI8897 Market Size, Forecast, and Market Insight - 2032

  • Report
  • February 2024
  • 30 Pages
  • Global
From
FLUZONE QUADRIVALENT Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FLUZONE QUADRIVALENT Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
FLUBLOK QUADRIVALENT Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FLUBLOK QUADRIVALENT Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
FLUAD QUADRIVALENT Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FLUAD QUADRIVALENT Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
FLUCELVAX QUADRIVALENT Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FLUCELVAX QUADRIVALENT Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
FLUMIST QUADRIVALENT Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FLUMIST QUADRIVALENT Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
FLUARIX QUADRIVALENT Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

FLUARIX QUADRIVALENT Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
Cancer Vaccines - Competitive landscape, 2023 - Product Thumbnail Image

Cancer Vaccines - Competitive landscape, 2023

  • Report
  • April 2023
  • 500 Pages
  • Global
From
Microbiome - Competitive landscape, 2023 - Product Thumbnail Image

Microbiome - Competitive landscape, 2023

  • Report
  • April 2023
  • 300 Pages
  • Global
From
Interferon - Biosimilar Insight, 2022 - Product Thumbnail Image

Interferon - Biosimilar Insight, 2022

  • Report
  • January 2022
  • 70 Pages
  • Global
From
Loading Indicator

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders. Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively. Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more